| Literature DB >> 32798760 |
Dechao Feng1, Shengzhuo Liu1, Yunjin Bai1, Yin Tang1, Ping Han1, Wuran Wei2.
Abstract
Since first reported in Dec.2019 in Wu Han, China, Novel Coronavirus has captured most cities in China. On Feb.1.2020, National Health Commission of the People's Republic of China (NHCC) officially termed the novel coronavirus as COVID-19, which is in accordance with World Health Organization (WHO). Until 14:35, Feb, 21, the number of diagnosed cases was 76,178 and 2247 died, among which 75,568 and 2239 were reported in China respectively with an estimated mortality of 2.9%. A comprehensive introduction of management strategy involving patients and their family, ward, protection and psychological adjustment of medical staff in urology department of West China Hospital during COVID-19 epidemic was summarized in this article, through which we hope could provide reference for other medical centers.Entities:
Keywords: COVID-19; Management; Urology
Mesh:
Year: 2020 PMID: 32798760 PMCID: PMC7425644 DOI: 10.1016/j.ijsu.2020.08.005
Source DB: PubMed Journal: Int J Surg ISSN: 1743-9159 Impact factor: 13.400
The basic knowledge acquainted by all caregivers.
| Epidemiological features | Infection sources | Patients with confirmed COVID-19 infection are the main source of infection. Asymptomatic COVID-19 infection can also become the source of infection. | |
| Transmission routes | The virus is mainly transmitted via droplets respiratory and close-contact. People are susceptible to infect through aerosols when constant exposed to high-concentration aerosol in a relatively closed environment. | ||
| Susceptible population | COVID-19 is prone to transmit in humans./COVID-19 is easily transmissible in the crowd. | ||
Diagnostic criteria | Suspected cases | Epidemiology history | History of travel to or residence in or around Wuhan, China or other cities with confirmed cases in the last 14 days before symptom onset; |
History of contact with confirmed COVID-19 cases which the nucleic acid test is positive in the last 14 days before symptom onset; | |||
History of contact with patients with fever or respiratory symptoms from Wuhan and adjacent district or other cities with confirmed cases in the last 14 days before symptom onset; | |||
Clustered onsets; | |||
Clinical features | Fever and/or respiratory symptoms; | ||
Typical imaging features of COVID-19; | |||
Reduced or normal white blood cell count, or reduced lymphocyte count in the early stage of the disease onset.; | |||
| Patients with any 2 of clinical features and any epidemiology history or no specific epidemiology history are suspected cases; | |||
Confirmed case | The real-time PCR test for COVID-19 nucleic acid is positive; | ||
The viral gene sequencing presents highly homogeneity to the known COVID-19; | |||
| Suspected cases with one of the above pathogenic evidence are considered as the confirmed cases; | |||
| Clinical classification | Mild | Patients with mild clinical symptom shows no imaging features of pneumonia; | |
| Moderate | Patients experience fever or respiratory symptoms while the imaging features are pneumonia; | ||
Severe | shortness of breath, respiratory rate (RR) < 30; | ||
Pulse oxygen saturation<93% in resting situation; | |||
Alveolar oxygen partial pressure (PaO2)/Fraction of inspiration oxygen ≤300 mmHg; | |||
Patients with imaging features which lesions are markedly progressed >50% in 24–48 hours are considered as the severe patients; | |||
Critical | Mechanical ventilation should be given to patients with hypoxic respiratory failure; | ||
Shock; | |||
Patients should be admitted to ICU when combine with multiple organ failure; | |||
Fig. 1Outpatient epidemiology declaration form.
Suspected cases of new coronavirus pneumonia screening Form.
Fig. 2Management for patients with suspected COVID-19 patients.